NEJM: Semaglutide Evaluated for Pediatric Obesity

WeightControl.com Interview with:
Prof. Dr. Daniel Weghuber
Head of Department
Department of Pediatrics
Paracelsus Medical University
Austria
President of the European Childhood Obesity Group

Prof. Dr. Weghuber

WeightControl.com:  What is the background for this study? 

Response: In this study, researchers looked at the effect of semaglutide on body mass index (BMI) and weight loss compared to a dummy medicine (placebo).

NEJM: Time-Restricted Eating in Weight Loss

Time-restricted eating combined with calorie restriction offer a viable and sustainable approach for person who wants to lose weight.

WeightControl.com Interview with:
Huijie Zhang   M.D. & Ph.D
Professor and Chief Physician
Deputy Director of Department of Endocrinology and Metabolism
Nafang Hospital of Southern Medical University
Guangzhou, China

WeightControl.com:  What is the background for this study?  What are the main findings?

Response: Time-restricted eating is one of the most popular intermittent fasting regimens involving a specific eating period within a 24-hour cycle. Time-restricted eating regimen has gained attention because it reduces weight and enhances adherence. The long-term efficacy and safety of time-restricted eating for weight loss are not clear.

In this randomized clinical trial, among patients with obesity, a regimen of time-restricted eating was not more beneficial with regard to reduction in body weight, body fat, or metabolic risk factors than daily calorie restriction.